0001104659-22-099283.txt : 20220912 0001104659-22-099283.hdr.sgml : 20220912 20220912170019 ACCESSION NUMBER: 0001104659-22-099283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220909 FILED AS OF DATE: 20220912 DATE AS OF CHANGE: 20220912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ende Eric J CENTRAL INDEX KEY: 0001494386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35963 FILM NUMBER: 221239129 MAIL ADDRESS: STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC. STREET 2: 1545 ROUTE 206 SOUTH, SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc. CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 350 TECHNOLOGY DRIVE CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: 412-763-3350 MAIL ADDRESS: STREET 1: 350 TECHNOLOGY DRIVE CITY: PITTSBURGH STATE: PA ZIP: 15219 FORMER COMPANY: FORMER CONFORMED NAME: Ohr Pharmaceutical Inc DATE OF NAME CHANGE: 20090819 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 4 1 tm2225655-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-09-09 0 0001173281 NeuBase Therapeutics, Inc. NBSE 0001494386 Ende Eric J C/O 350 TECHNOLOGY DRIVE, FOURTH FLOOR PITTSBURGH PA 15219 1 0 0 0 Stock option (right to buy) 0.60 2022-09-09 4 A 0 37600 0 A 2032-09-09 Common Stock 37600 37600 D 25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months. The power of attorney under which this form was signed is on file with the Commission. /s/ Todd Branning, as attorney-in-fact for Eric J. Ende 2022-09-12